• OPEN AN ACCOUNT
Indian Indices
Nifty
25,103.20 100.15
(0.40%)
Sensex
82,523.95 78.74
( 0.10%)
Bank Nifty
56,839.60 261.20
( 0.46%)
Nifty IT
37,669.20 374.35
( 1.00%)
Global Indices
Nasdaq
42,777.23 -6.65
(-0.02%)
Dow Jones
6,025.66 4.30
(0.07%)
Hang Seng
38,084.54 342.93
(0.91%)
Nikkei 225
8,832.28 -5.63
(-0.06%)
Forex
USD-INR
85.75 -0.02
(-0.02%)
EUR-INR
97.72 -0.17
(-0.18%)
GBP-INR
115.95 -0.20
(-0.17%)
JPY-INR
0.59 0.00
(-0.36%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
411.1031908
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
57.21
1138.33
EPS(TTM)
Face Value()
Div & Yield %
33.77
10
0
 

asian tea & exports ltd
Shri Vasuprada Plantations reports consolidated net profit of Rs 0.78 crore in the March 2025 quarter
May 17,2025
Net profit of Shri Vasuprada Plantations reported to Rs 0.78 crore in the quarter ended March 2025 as against net loss of Rs 7.31 crore during the previous quarter ended March 2024. Sales rose 106.34% to Rs 32.87 crore in the quarter ended March 2025 as against Rs 15.93 crore during the previous quarter ended March 2024.

For the full year,net profit reported to Rs 6.10 crore in the year ended March 2025 as against net loss of Rs 6.63 crore during the previous year ended March 2024. Sales rose 23.03% to Rs 132.40 crore in the year ended March 2025 as against Rs 107.62 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales32.8715.93 106 132.40107.62 23
OPM %6.81-17.07 -4.44-8.45 -
PBDT-2.99-5.95 50 2.63-11.85 LP
PBT-4.11-7.85 48 -3.82-19.34 80
NP0.78-7.31 LP 6.10-6.63 LP